Royal Bank of Canada »

Relmada Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $17k 4.2k 4.15
2023-09-30 $2.0k 584 3.42
2023-06-30 $3.0k 1.1k 2.75
2022-12-31 $33k 10k 3.20
2022-09-30 $246k 6.7k 37.00
2021-06-30 $305k 9.5k 32.00
2021-03-31 $322k 9.3k 34.75
2020-12-31 $783k 24k 32.08
2020-09-30 $919k 24k 37.63
2020-06-30 $999 26 38.46
2019-12-31 $1.0k 36 27.78